Ligand validation:8H5P

4WI: (1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide

4WI is a Ligand Of Interest in 8H5P designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8H5P_4WI_A_401	70%	5%	0.097	0.913	3.59	1.81	12	9	0	0	100%	1
8DZ9_4WI_A_401	96%	43%	0.063	0.972	0.88	1.3	2	3	3	0	100%	1
8EYJ_4WI_A_401	95%	65%	0.069	0.974	0.57	0.78	1	1	0	0	100%	1
8C9U_4WI_AAA_401	89%	69%	0.069	0.946	0.57	0.61	-	-	0	0	100%	1
8DZ2_4WI_A_401	81%	67%	0.101	0.954	0.54	0.74	-	1	0	0	100%	1
9AUM_4WI_A_401	81%	29%	0.082	0.934	1.59	1.27	5	3	0	0	100%	1
7UJU_4WI_A_401	89%	59%	0.079	0.957	0.66	0.9	-	2	0	0	100%	1
7YRZ_4WI_A_401	82%	19%	0.091	0.946	2.21	1.27	5	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.